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Pelvic floor muscle training reduces erectile dysfunction 
and climacturia one year after open and robot radical 
prostatectomy: a randomized controlled trial. 
 
 
To determine whether patients, with 
remaining erectile dysfunction (ED), 
minimum 12 months after radical 
prostatectomy (RP), experienced a 
better recovery of erectile function (EF) 
with pelvic floor muscle training (PFMT).  
To investigate the effect of PFMT on 
climacturia. 
 
ED remains a significant problem for 19-
74% of men undergoing a nerve sparing 
RP.1 
Only one RCT was reported regarding 
the effect of ED after RP, indicating 
improved EF. PFMT was however 
started immediately after catheter 
removal, without taking into account a 
period of spontaneous recovery of EF.2 
 
 
 Evaluation of ED/ climacturia: 
 - International Index of Erectile  
   Function (IIEF)/ interview (yes/no) 
 Inclusion criteria 
- 33 patients, who underwent 
   ORP/RALP and were closely     
   followed in previous research3  
- Suffering from ED, min. 1 yr after RP 
 Exclusion criteria  
    - Remaining urinary incontinence 
    - No female partner 
    - Preoperative IIEF-EF score ≤12  
    - IIEF-EF score >24 at time of inclusion 
    - Post-RP radiation therapy  
    - Non-nerve sparing RP 
    - No interruption of other erectile aids 
 Treatment group (T): started PFMT 
immediately at inclusion; control group 
(C): started PFMT 3 months later 
 Statistical analysis of differences 
between groups at 3 months: Mann 
Whitney U test, Fisher’s exact test 
 Thirty-three patients were included: N=17 (T), n= 16 (C) 
 Mean age (T) 61.1 years (SD 5.8), (C) 61.5 years (SD 7.3); in (T) 
and (C), respectively 81% and 65% underwent an open RP and 19% 
and 35% a robot RP. Mean preoperative IIEF-EF was 26.9 (SD 3.8) 
in (T) and 23.8 (SD 6.8) in (C). Mean IIEF-EF score at inclusion was 
6.7 (SD 6.3) in (T) and 9.5 (SD 7.3) in (C).  
 At 3 months after starting PFMT, (T)  had a significantly better EF 
than (C) (p=0.025) (Figure 1a/1b).  
 Other subdomains of the IIEF, like orgasmic function, sexual desire, 
intercourse satisfaction and overall satisfaction remained the same.  
 At 3 months after starting PFMT, a significantly higher percentage of 
patients  in (T) showed an improvement regarding climacturia 
(p=0.004) (Table 1). 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 Patients, minimum 12 months after RP, with remaining ED, 
experienced a better recovery of EF with PFMT compared to patients 
without PFMT. 
 PFMT had a beneficial effect on climacturia.  
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Table 1 Number (percentage) of patients suffering from climacturia at each time-point  
Treatment group 
(N=16) 
Control group 
(N=17) 
  
0 months 9/16 (56%) 7/17 (41%)   
3 months             3/14 (21%)after PFMT 8/17 (47%)   
6 months 4/14 (29%)              2/16 (12%) after PFMT   
9 months  4/16 (25%)   
* Fisher’s exact-statistics (p=0.004), indicating the difference in proportion of patients with climacturia 
between (T) and (C) at 3 months. 
Figure 1 Individual evolution of erectile function over time for the treatment group  
Figure 1a/1b Individual evolution of erectile function over time for the treatment and control group 
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